4.7 Article

Anodic Titanium Dioxide Nanotubes for Magnetically Guided Therapeutic Delivery

Journal

SCIENTIFIC REPORTS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-019-49513-2

Keywords

-

Funding

  1. Georg Forster Research Fellowship from the Alexander von HumboldtFoundation
  2. Alexander von Humboldt-Foundation
  3. European Union
  4. Deutsche Forschungsgemeinschaft

Ask authors/readers for more resources

Hollow titanium dioxide (TiO2) nanotubes offer substantially higher drug loading capacity and slower drug release kinetics compared to solid drug nanocarriers of comparable size. In this report, we load TiO2 nanotubes with iron oxide nanoparticles to facilitate site-specific magnetic guidance and drug delivery. We generate magnetic TiO(2 )nanotubes (TiO2 NTs) by incorporating a ferrofluid containing empty set approximate to 10 nm iron oxide nanoparticles in planar sheets of weakly connected TiO2 nanotubes. After thermal annealing, the magnetic tubular arrays are loaded with therapeutic drugs and then sonicated to separate the nanotubes. We demonstrate that magnetic TiO2 NTs are non-toxic for HeLa cells at therapeutic concentrations (<= 200 mu g/mL). Adhesion and endocytosis of magnetic nanotubes to a layer of HeLa cells are increased in the presence of a magnetic gradient field. As a proof-of-concept, we load the nanotubes with the topoisomerase inhibitor camptothecin and achieve a 90% killing efficiency. We also load the nanotubes with oligonucleotides for cell transfection and achieve 100% cellular uptake efficiency. Our results demonstrate the potential of magnetic TiO2 NTs for a wide range of biomedical applications, including site-specific delivery of therapeutic drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available